The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 2.21
All Cancer Sites (Invasive)
United States Cancer Prevalence Estimates
Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity, Sex and Years Since Diagnosis
| Race/Ethnicity | Sex | Years Since Diagnosis | Completee | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 to 5 | >5 to 10 | >10 to 15 | >15 to 20 | >20 to 25 | <=25b | >25d | |||
| All Races | Both Sexes | 4,863,591 | 3,678,954 | 2,671,940 | 1,874,577 | 1,156,722 | 14,245,784 | 1,515,155 | 15,760,939 |
| Males | 2,338,455 | 1,857,458 | 1,307,418 | 852,831 | 477,140 | 6,833,302 | 397,509 | 7,230,811 | |
| Females | 2,525,136 | 1,821,495 | 1,364,523 | 1,021,746 | 679,582 | 7,412,482 | 1,117,646 | 8,530,128 | |
| White | Both Sexes | 4,024,750 | 3,103,763 | 2,301,691 | 1,639,332 | 1,019,739 | 12,089,276 | 1,304,407 | 13,393,683 |
| Males | 1,927,986 | 1,556,489 | 1,120,549 | 741,727 | 420,910 | 5,767,660 | 356,439 | 6,124,100 | |
| Females | 2,096,765 | 1,547,275 | 1,181,142 | 897,605 | 598,830 | 6,321,616 | 947,968 | 7,269,584 | |
| Black | Both Sexes | 522,353 | 366,426 | 243,349 | 153,030 | 87,254 | 1,372,412 | 107,632 | 1,480,045 |
| Males | 258,109 | 197,693 | 128,021 | 76,937 | 38,045 | 698,805 | 20,401 | 719,206 | |
| Females | 264,244 | 168,733 | 115,328 | 76,093 | 49,209 | 673,608 | 87,231 | 760,839 | |
| Asian/ Pacific Islander |
Both Sexes | 183,298 | 121,582 | 80,129 | 51,196 | 29,176 | 465,381 | + | + |
| Males | 72,929 | 49,034 | 31,005 | 17,917 | 9,032 | 179,916 | + | + | |
| Females | 110,369 | 72,548 | 49,124 | 33,279 | 20,144 | 285,465 | + | + | |
| Hispanic | Both Sexes | 408,638 | 276,391 | 184,454 | 116,896 | 68,716 | 1,055,094 | + | + |
| Males | 177,231 | 127,177 | 83,223 | 49,354 | 25,903 | 462,888 | + | + | |
| Females | 231,407 | 149,214 | 101,232 | 67,542 | 42,812 | 592,206 | + | + | |
Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence, Race/Ethnicity and Sex
| Race/Ethnicity | Sex | Age Specific (Crude) | Age-Adjustedc | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Ages | 0-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60-69 | 70-79 | 80+ | All Ages | ||
| All Races | Both Sexes | 4.3954 | 0.0901 | 0.2070 | 0.4041 | 0.9211 | 2.1986 | 5.0523 | 10.5439 | 18.5788 | 22.1076 | 3.7298 |
| Males | 4.2813 | 0.0920 | 0.2200 | 0.3959 | 0.7363 | 1.4994 | 3.9928 | 10.6625 | 22.1101 | 29.8954 | 3.9647 | |
| Females | 4.5060 | 0.0881 | 0.1934 | 0.4127 | 1.1074 | 2.8862 | 6.0653 | 10.4365 | 15.6244 | 17.2583 | 3.6235 | |
| White | Both Sexes | 4.7774 | 0.0947 | 0.2237 | 0.4462 | 1.0025 | 2.3143 | 5.1610 | 10.6316 | 18.8503 | 22.5479 | 3.8150 |
| Males | 4.5989 | 0.0958 | 0.2385 | 0.4391 | 0.8084 | 1.5833 | 3.9945 | 10.4705 | 21.9382 | 29.9112 | 3.9716 | |
| Females | 4.9527 | 0.0935 | 0.2081 | 0.4537 | 1.2035 | 3.0536 | 6.3009 | 10.7809 | 16.2101 | 17.8801 | 3.7752 | |
| Black | Both Sexes | 3.0132 | 0.0672 | 0.1434 | 0.2520 | 0.6091 | 1.6838 | 4.5141 | 10.4660 | 17.5131 | 18.6314 | 3.3375 |
| Males | 3.1967 | 0.0714 | 0.1455 | 0.2433 | 0.4611 | 1.1542 | 4.1869 | 12.7224 | 24.8331 | 29.8122 | 4.1795 | |
| Females | 2.8439 | 0.0629 | 0.1412 | 0.2608 | 0.7458 | 2.1530 | 4.7992 | 8.6631 | 12.3947 | 13.0482 | 2.8361 | |
| Asian/ Pacific Islander |
Both Sexes | 2.2316 | 0.0756 | 0.1492 | 0.2405 | 0.5355 | 1.5093 | 3.5040 | 6.7079 | 10.7417 | 13.4818 | 2.3412 |
| Males | 1.7996 | 0.0780 | 0.1624 | 0.2220 | 0.3636 | 0.7925 | 2.0939 | 5.5224 | 11.5436 | 17.2364 | 2.1409 | |
| Females | 2.6294 | 0.0732 | 0.1358 | 0.2591 | 0.6920 | 2.1434 | 4.7256 | 7.6631 | 10.0999 | 11.0339 | 2.5440 | |
| Hispanic | Both Sexes | 1.8149 | 0.0836 | 0.1966 | 0.3481 | 0.6952 | 1.5731 | 3.5145 | 7.3612 | 12.8691 | 15.3187 | 2.6454 |
| Males | 1.5761 | 0.0868 | 0.2121 | 0.3525 | 0.5450 | 0.9735 | 2.4303 | 6.7974 | 15.3010 | 21.5215 | 2.7366 | |
| Females | 2.0588 | 0.0802 | 0.1805 | 0.3433 | 0.8587 | 2.1895 | 4.5874 | 7.8620 | 10.9951 | 11.4686 | 2.6693 | |
Footnotes:
a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.
b Maximum limited-duration prevalence is 25 years for 1992-2017 data.
c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.
d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).
e Complete prevalence is obtained by summing <=25 and >25.
- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.
+ Not available.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.